Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
Louise Marchandet, Morgane Lallier, Céline Charrier, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 683-683
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Osteosarcoma mechanobiology and therapeutic targets
Zunaira Shoaib, Timothy M. Fan, Joseph Irudayaraj
British Journal of Pharmacology (2021) Vol. 179, Iss. 2, pp. 201-217
Open Access | Times Cited: 118
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
Claudia Maria Hattinger, Maria Pia Patrizio, Leonardo Fantoni, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2878-2878
Open Access | Times Cited: 82
An overview of resistance to chemotherapy in osteosarcoma and future perspectives
Dorian Yarih García-Ortega, Sara Aileen Cabrera-Nieto, Haydee Sarai Caro-Sánchez, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 2, pp. 762-93
Open Access | Times Cited: 40
Recent advances on nanostructured biomaterials in osteosarcoma treatment
Chengcheng Feng, Yechun Jiang, Tao Wang, et al.
Coordination Chemistry Reviews (2023) Vol. 493, pp. 215315-215315
Closed Access | Times Cited: 23
Activated aggregation‐induced emission therapeutics agents for triggering regulated cell death
Yu‐Qiang Zhao, Le Yu, Lanyun Zhang, et al.
Aggregate (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 10
Multi-omics analysis based on 3D-bioprinted models innovates therapeutic target discovery of osteosarcoma
Yixuan Lin, Yiqi Yang, Kai Yuan, et al.
Bioactive Materials (2022) Vol. 18, pp. 459-470
Open Access | Times Cited: 28
Application of advanced biomaterials in photothermal therapy for malignant bone tumors
Chao Bo, Jianhang Jiao, Lili Yang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 16
Functional inorganic nanomaterials for optical cancer theranostics
Kai Song, Xiaomeng Su, Wei Zhao, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 150067-150067
Closed Access | Times Cited: 7
Novel Perspectives towards RNA-Based Nano-Theranostic Approaches for Cancer Management
Rabia Arshad, Iqra Fatima, Saman Sargazi, et al.
Nanomaterials (2021) Vol. 11, Iss. 12, pp. 3330-3330
Open Access | Times Cited: 40
Multiple Effects of Resveratrol on Osteosarcoma Cell Lines
Angela De Luca, Daniele Bellavia, Lavinia Raimondi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 342-342
Open Access | Times Cited: 25
Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma
Xiaozhuo Gao, Bo Gao, Shenglong Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Single-step synthesis of self-assembled carbon dots for enhanced cancer cell retention and theranostics applications
Sindeesh Reddy Padidam, Devyani Balasaheb Kadam, Saichand Thakkellapati, et al.
Microchemical Journal (2024) Vol. 198, pp. 110144-110144
Closed Access | Times Cited: 5
Drug resistance in human cancers — Mechanisms and implications
Sudikshaa Vijayakumar, Raveena Dhakshanamoorthy, Akshaya Baskaran, et al.
Life Sciences (2024) Vol. 352, pp. 122907-122907
Closed Access | Times Cited: 5
Review of the role and potential clinical value of m6A methylation modifications in the biological process of osteosarcoma
Huaqiang Zhou, Rongbing Shu, Jianming Wu, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
IRF7 inhibits the Warburg effect via transcriptional suppression of PKM2 in osteosarcoma
Zhikun Li, Mei Geng, Xiaojian Ye, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 1, pp. 30-42
Open Access | Times Cited: 31
Osteosarcoma in Children: Not Only Chemotherapy
Maura Argenziano, Chiara Tortora, Elvira Pota, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 923-923
Open Access | Times Cited: 30
Data-Driven Mathematical Model of Osteosarcoma
Trang Le, Sumeyye Su, Arkadz Kirshtein, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2367-2367
Open Access | Times Cited: 29
Long Intergenic Noncoding RNA00265 Enhances Cell Viability and Metastasis via Targeting miR-485-5p/USP22 Axis in Osteosarcoma
Ting Chen, Jinxin Liu, He Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma
Jie Cao, C. Zhu, Ziqi Cao, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 130915-130915
Closed Access | Times Cited: 4
Tumor‐On‐A‐Chip Model Incorporating Human‐Based Hydrogels for Easy Assessment of Metastatic Tumor Inter‐Heterogeneity
Cátia F. Monteiro, Inês A. Deus, Inês Silva, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Open Access | Times Cited: 4
Nanotechnology revolutionizing osteosarcoma treatment: Advances in targeted kinase inhibitors
Yongtao Zhang, Chao Zhou, Qiong Xie, et al.
Nanotechnology Reviews (2025) Vol. 14, Iss. 1
Open Access
Advancements in Osteosarcoma Therapy: Overcoming Chemotherapy Resistance and Exploring Novel Pharmacological Strategies
Mahmoud Zhra, Shahid Akhtar Akhund, Khalid S. Mohammad
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 520-520
Open Access
Overview of biodegradable materials for bone repair and osteosarcoma treatment: From bulk to scaffolds
Shebeer A. Rahim, Hamid Reza Bakhsheshi‐Rad, Joseph J. Licavoli, et al.
Biomaterials Advances (2025), pp. 214317-214317
Closed Access
USP7 promotes the malignant progression of osteosarcoma through the KPNA2/PKLR axis
Mao Wang, Yuxia Shi, Zhizhong Liang, et al.
Cellular Signalling (2025), pp. 111819-111819
Closed Access
Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy
Hongzhi Hu, Wenbo Yang, Zihui Liang, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top